Paulson’s Hedge Fund Urges Botox-Maker Allergan to Consider Buying Shire

NYT – If AbbVie no longer wants to buy Shire, perhaps Allergan does.

That is the proposal being pushed by Paulson & Company, the hedge fund that has stakes in two of those big drug makers, according to people briefed on the matter.

Read Complete Article

This entry was posted in Syndicated. Bookmark the permalink.

Leave a Reply